‘Resolve, Directing the Department of Professional and Financial Regulation, State Board of Nursing To Amend the Rules for the Medication Course for Certified Nursing Assistants’
| SP0570 LD 1626 |
First Regular Session - 123rd Maine Legislature C "A", Filing Number S-146
Text:
MS-Word, RTF or PDF
|
LR 1845 Item 2 |
|
| Bill Tracking | Chamber Status | ||
Amend the bill by striking out the title and substituting the following:
‘Resolve, Directing the Department of Professional and Financial Regulation, State Board of Nursing To Amend the Rules for the Medication Course for Certified Nursing Assistants’
Amend the bill by striking out everything after the title and before the summary and inserting the following:
‘Sec. 1. Department of Professional and Financial Regulation, State Board of Nursing directed to amend rules for the medication course for certified nursing assistants. Resolved: That the Department of Professional and Financial Regulation, State Board of Nursing shall amend its rules relating to the State Board of Nursing's standardized medication course for certified nursing assistants to increase the clinical instructor-to-student ratio from 1:1 when the student is administering medications in the clinical setting to a ratio of 1:3. The board shall adopt routine technical rules to increase the ratio to 1:3 pursuant to the Maine Revised Statutes, Title 5, chapter 375, subchapter 2-A; and be it further
Sec. 2. Reporting date established. Resolved: That, by September 1, 2008, the Department of Professional and Financial Regulation, State Board of Nursing shall notify the Joint Standing Committee on Business, Research and Economic Development of the rule change under section 1.’
summary
This amendment replaces the bill with a resolve that directs the Department of Professional and Financial Regulation, State Board of Nursing to amend its rules for the board's standardized medication course for certified nursing assistants to increase the clinical instructor-to-student ratio from 1:1 when the student is administering medications in the clinical setting to a ratio of 1:3. The amendment also requires the board to notify the Joint Standing Committee on Business, Research and Economic Development of the rule change by September 1, 2008.